Treatment with Kalydeco (ivacaftor) significantly reduces the levels of inflammatory molecules in the lungs of preschool-age children with…
Articles by Marisa Wexler, MS
The government of Ontario has expanded coverage of Vertex Pharmaceuticals’ triple-combination treatment Trikafta for children, 6 and older, with…
A technique called 2D shear wave elastography, which measures the stiffness of tissues, could be useful for detecting liver disease…
Treatment with the probiotic Vivomixx appeared to lead to healthful changes in the…
A newly launched biotech company called Carbon Biosciences is aiming to develop lung-specific gene therapy vectors — vehicles to deliver…
Using a machine learning approach based on genetic data, a trio of scientists at Scripps Research identified a region of…
The Lung Transplant Foundation is hosting a meeting with the U.S. Food and Drug Administration (FDA) with the intent of…
Certain variations in the gene that codes for the inflammatory signaling molecule TGF-beta1 are associated with faster lung function decline…
There is wide clinical variety in the presentation of individuals who carry one F508del mutation and one 5T;TG12 mutation in…
Infants with cystic fibrosis (CF) who are infected with Pseudomonas aeruginosa in their first six months are at heightened…